Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of medicines in China. The company offers drugs in the fields of pediatrics, respiratory system, digestive system, and gynecology. It is also involved in daily chemical product sales; and wholesale and retail pharmaceuticals. The company is headquartered in Taixing, China.
Research context
Hubei Jumpcan Pharmaceutical Co., Ltd appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Hubei Jumpcan Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 15.1% below its 200 day moving average.
From a valuation standpoint, the stock is 70.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.8.
Hubei Jumpcan Pharmaceutical Co., Ltd's total revenue sank by 7.9% to $1B since the same quarter in the previous year.
Its net income has dropped by 19.6% to $275M since the same quarter in the previous year.
Finally, its free cash flow fell by 76.1% to $132M since the same quarter in the previous year.
Based on the above factors, Hubei Jumpcan Pharmaceutical Co., Ltd gets an overall score of 1/5.